TickerFactsScreenerDevelopers

RIGEL PHARMACEUTICALS INC (RIGL) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$112.04M2010: $35.32M2011: -$86.37M2012: -$99.38M2013: -$89.47M2014: -$91.25M2015: -$51.74M2016: -$69.74M2017: -$79.62M2018: -$72.68M2019: -$69.09M2020: -$28.97M2021: -$12.50M2022: -$55.55M2023: -$20.49M2024: $24.19M2025: $125.47M$125.47M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$125.47M+418.6%
2024$24.19M+218.1%
2023-$20.49M+63.1%
2022-$55.55M-344.5%
2021-$12.50M+56.9%
2020-$28.97M+58.1%
2019-$69.09M+4.9%
2018-$72.68M+8.7%
2017-$79.62M-14.2%
2016-$69.74M-34.8%
2015-$51.74M+43.3%
2014-$91.25M-2.0%
2013-$89.47M+10.0%
2012-$99.38M-15.1%
2011-$86.37M-344.6%
2010$35.32M+131.5%
2009-$112.04M—